

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.13501204 |
| 2 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.94289401 |
| 3 | vocalization behavior (GO:0071625) | 4.87582334 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.86270223 |
| 5 | glutamate receptor signaling pathway (GO:0007215) | 4.76670072 |
| 6 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.48098830 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.47505643 |
| 8 | locomotory exploration behavior (GO:0035641) | 4.47200280 |
| 9 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.36026987 |
| 10 | synaptic vesicle exocytosis (GO:0016079) | 4.27428336 |
| 11 | synaptic transmission, glutamatergic (GO:0035249) | 4.27150305 |
| 12 | glutamate secretion (GO:0014047) | 4.26614519 |
| 13 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.24999679 |
| 14 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.19927050 |
| 15 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.17432300 |
| 16 | positive regulation of synapse maturation (GO:0090129) | 4.15197992 |
| 17 | protein localization to synapse (GO:0035418) | 4.08724839 |
| 18 | synaptic vesicle maturation (GO:0016188) | 3.95530057 |
| 19 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.92443435 |
| 20 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.90236042 |
| 21 | NADH metabolic process (GO:0006734) | 3.89839309 |
| 22 | long-term memory (GO:0007616) | 3.86526874 |
| 23 | neuron-neuron synaptic transmission (GO:0007270) | 3.84623461 |
| 24 | exploration behavior (GO:0035640) | 3.80635398 |
| 25 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.79861633 |
| 26 | cellular potassium ion homeostasis (GO:0030007) | 3.79720659 |
| 27 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.78031077 |
| 28 | behavioral defense response (GO:0002209) | 3.77640469 |
| 29 | behavioral fear response (GO:0001662) | 3.77640469 |
| 30 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.69365369 |
| 31 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.64626477 |
| 32 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.64587224 |
| 33 | regulation of synaptic plasticity (GO:0048167) | 3.55692505 |
| 34 | macroautophagy (GO:0016236) | 3.53602986 |
| 35 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.48729744 |
| 36 | cell communication by electrical coupling (GO:0010644) | 3.46417500 |
| 37 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.44375211 |
| 38 | regulation of postsynaptic membrane potential (GO:0060078) | 3.41062648 |
| 39 | fear response (GO:0042596) | 3.38992715 |
| 40 | angiotensin maturation (GO:0002003) | 3.38373048 |
| 41 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.38064310 |
| 42 | neuronal action potential propagation (GO:0019227) | 3.37820066 |
| 43 | dendritic spine organization (GO:0097061) | 3.37659414 |
| 44 | regulation of synaptic vesicle transport (GO:1902803) | 3.36611356 |
| 45 | long-term synaptic potentiation (GO:0060291) | 3.33477688 |
| 46 | sodium ion export (GO:0071436) | 3.33030509 |
| 47 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.32322633 |
| 48 | labyrinthine layer development (GO:0060711) | 3.28766645 |
| 49 | dendritic spine morphogenesis (GO:0060997) | 3.26463400 |
| 50 | response to histamine (GO:0034776) | 3.25615791 |
| 51 | regulation of synapse maturation (GO:0090128) | 3.22649639 |
| 52 | neurotransmitter secretion (GO:0007269) | 3.22627031 |
| 53 | neuron recognition (GO:0008038) | 3.22581733 |
| 54 | regulation of synapse structural plasticity (GO:0051823) | 3.22419909 |
| 55 | membrane depolarization during action potential (GO:0086010) | 3.20232058 |
| 56 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.19926090 |
| 57 | serotonin metabolic process (GO:0042428) | 3.19284958 |
| 58 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.18879404 |
| 59 | neuron cell-cell adhesion (GO:0007158) | 3.18855375 |
| 60 | transmission of nerve impulse (GO:0019226) | 3.16428436 |
| 61 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.16086337 |
| 62 | innervation (GO:0060384) | 3.15483442 |
| 63 | positive regulation of membrane potential (GO:0045838) | 3.15465412 |
| 64 | skeletal muscle adaptation (GO:0043501) | 3.15431473 |
| 65 | relaxation of cardiac muscle (GO:0055119) | 3.13218145 |
| 66 | regulation of bile acid biosynthetic process (GO:0070857) | 3.12959891 |
| 67 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.11284743 |
| 68 | gamma-aminobutyric acid transport (GO:0015812) | 3.07806381 |
| 69 | intestinal absorption (GO:0050892) | 3.07297558 |
| 70 | histone H3-K36 demethylation (GO:0070544) | 3.06660829 |
| 71 | regulation of ARF protein signal transduction (GO:0032012) | 3.06382569 |
| 72 | startle response (GO:0001964) | 3.05260912 |
| 73 | inner ear receptor cell development (GO:0060119) | 3.02751022 |
| 74 | renal absorption (GO:0070293) | 3.02195896 |
| 75 | axonal fasciculation (GO:0007413) | 2.99419981 |
| 76 | negative regulation of hormone metabolic process (GO:0032351) | 2.98988743 |
| 77 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.98825274 |
| 78 | membrane depolarization (GO:0051899) | 2.98265854 |
| 79 | long term synaptic depression (GO:0060292) | 2.97337866 |
| 80 | chemosensory behavior (GO:0007635) | 2.95757090 |
| 81 | regulation of vesicle fusion (GO:0031338) | 2.94656952 |
| 82 | dendrite morphogenesis (GO:0048813) | 2.93993877 |
| 83 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.93016790 |
| 84 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.91033954 |
| 85 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.90536390 |
| 86 | regulation of guanylate cyclase activity (GO:0031282) | 2.90437065 |
| 87 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.90287775 |
| 88 | learning (GO:0007612) | 2.88303925 |
| 89 | regulation of relaxation of muscle (GO:1901077) | 2.87322943 |
| 90 | primary amino compound metabolic process (GO:1901160) | 2.87265044 |
| 91 | cell communication involved in cardiac conduction (GO:0086065) | 2.87226091 |
| 92 | regulation of glutamate secretion (GO:0014048) | 2.86762786 |
| 93 | synaptic vesicle endocytosis (GO:0048488) | 2.86151818 |
| 94 | positive regulation of dendritic spine development (GO:0060999) | 2.85454137 |
| 95 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.85190814 |
| 96 | cellular glucuronidation (GO:0052695) | 2.81945341 |
| 97 | glucan catabolic process (GO:0009251) | 2.81548747 |
| 98 | regulation of cholesterol homeostasis (GO:2000188) | 2.79977655 |
| 99 | proline transport (GO:0015824) | 2.79078634 |
| 100 | detection of calcium ion (GO:0005513) | 2.78995493 |
| 101 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.78851191 |
| 102 | negative regulation of amino acid transport (GO:0051956) | 2.78249947 |
| 103 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.78079918 |
| 104 | regulation of synaptic transmission (GO:0050804) | 2.77375229 |
| 105 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.77144950 |
| 106 | activation of protein kinase A activity (GO:0034199) | 2.75625385 |
| 107 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.74996049 |
| 108 | endocrine process (GO:0050886) | 2.74996049 |
| 109 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.74996049 |
| 110 | oocyte development (GO:0048599) | 2.74278139 |
| 111 | regulation of acrosome reaction (GO:0060046) | 2.73857505 |
| 112 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.73293248 |
| 113 | neurotransmitter transport (GO:0006836) | 2.73148557 |
| 114 | regulation of dendritic spine development (GO:0060998) | 2.73106050 |
| 115 | regulation of cell communication by electrical coupling (GO:0010649) | 2.71754533 |
| 116 | sulfate transmembrane transport (GO:1902358) | 2.70572902 |
| 117 | synaptic transmission (GO:0007268) | 2.68448263 |
| 118 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.66429150 |
| 119 | actin-myosin filament sliding (GO:0033275) | 2.64966852 |
| 120 | muscle filament sliding (GO:0030049) | 2.64966852 |
| 121 | epoxygenase P450 pathway (GO:0019373) | 2.64904985 |
| 122 | cochlea development (GO:0090102) | 2.64667540 |
| 123 | regulation of female receptivity (GO:0045924) | 2.62355417 |
| 124 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.62051618 |
| 125 | associative learning (GO:0008306) | 2.61639441 |
| 126 | neuromuscular process controlling balance (GO:0050885) | 2.60984051 |
| 127 | cellular polysaccharide catabolic process (GO:0044247) | 2.60839406 |
| 128 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.58782596 |
| 129 | interkinetic nuclear migration (GO:0022027) | 2.58397172 |
| 130 | lipoprotein transport (GO:0042953) | 2.57885677 |
| 131 | cGMP-mediated signaling (GO:0019934) | 2.57739956 |
| 132 | L-amino acid import (GO:0043092) | 2.57282857 |
| 133 | behavioral response to cocaine (GO:0048148) | 2.56839807 |
| 134 | * cellular sodium ion homeostasis (GO:0006883) | 2.56239402 |
| 135 | potassium ion import (GO:0010107) | 2.56114394 |
| 136 | regulation of protein glycosylation (GO:0060049) | 2.56064980 |
| 137 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.56046481 |
| 138 | positive regulation of fibroblast migration (GO:0010763) | 2.55082044 |
| 139 | regulation of neurotransmitter levels (GO:0001505) | 2.54648182 |
| 140 | regulation of p38MAPK cascade (GO:1900744) | 2.53996613 |
| 141 | citrulline biosynthetic process (GO:0019240) | 2.53337646 |
| 142 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.53145570 |
| 143 | uronic acid metabolic process (GO:0006063) | 2.51917607 |
| 144 | glucuronate metabolic process (GO:0019585) | 2.51917607 |
| 145 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.51839378 |
| 146 | actin-mediated cell contraction (GO:0070252) | 2.51807955 |
| 147 | memory (GO:0007613) | 2.51560898 |
| 148 | regulation of energy homeostasis (GO:2000505) | 2.51537759 |
| 149 | Golgi to endosome transport (GO:0006895) | 2.50592883 |
| 150 | glycogen catabolic process (GO:0005980) | 2.50446821 |
| 151 | regulation of actin filament-based movement (GO:1903115) | 2.50227213 |
| 152 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.48170552 |
| 153 | striated muscle hypertrophy (GO:0014897) | 2.47828703 |
| 154 | striated muscle contraction (GO:0006941) | 2.47523494 |
| 155 | early endosome to late endosome transport (GO:0045022) | 2.47395232 |
| 156 | relaxation of muscle (GO:0090075) | 2.45886878 |
| 157 | striated muscle adaptation (GO:0014888) | 2.43951639 |
| 158 | actin filament-based movement (GO:0030048) | 2.43887382 |
| 159 | flavonoid metabolic process (GO:0009812) | 2.43870060 |
| 160 | cardiac muscle contraction (GO:0060048) | 2.43402550 |
| 161 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.41225637 |
| 162 | skeletal muscle contraction (GO:0003009) | 2.40974277 |
| 163 | female mating behavior (GO:0060180) | 2.39753668 |
| 164 | cardiac muscle hypertrophy (GO:0003300) | 2.36506386 |
| 165 | creatine metabolic process (GO:0006600) | 2.35157632 |
| 166 | transcytosis (GO:0045056) | 2.34283942 |
| 167 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.34129114 |
| 168 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.33993789 |
| 169 | positive regulation of sodium ion transport (GO:0010765) | 2.33684107 |
| 170 | succinate metabolic process (GO:0006105) | 2.33035806 |
| 171 | phospholipid dephosphorylation (GO:0046839) | 2.32962055 |
| 172 | auditory receptor cell differentiation (GO:0042491) | 2.32537738 |
| 173 | energy homeostasis (GO:0097009) | 2.32393337 |
| 174 | cellular response to reactive nitrogen species (GO:1902170) | 2.32307782 |
| 175 | cardiac conduction (GO:0061337) | 2.32061315 |
| 176 | actin filament depolymerization (GO:0030042) | 2.31684400 |
| 177 | striated muscle atrophy (GO:0014891) | 2.30081752 |
| 178 | * sodium ion homeostasis (GO:0055078) | 2.29831763 |
| 179 | polysaccharide catabolic process (GO:0000272) | 2.29146473 |
| 180 | peptide hormone processing (GO:0016486) | 2.27878391 |
| 181 | regulation of skeletal muscle contraction (GO:0014819) | 2.27189749 |
| 182 | amino-acid betaine transport (GO:0015838) | 2.26936262 |
| 183 | carnitine transport (GO:0015879) | 2.26936262 |
| 184 | brain morphogenesis (GO:0048854) | 2.26307349 |
| 185 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.25245357 |
| 186 | nucleus localization (GO:0051647) | 2.24688818 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.47564633 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.67024803 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.92850019 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.85748795 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.80048823 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.68243067 |
| 7 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.53353925 |
| 8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.50468978 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.46813000 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.46813000 |
| 11 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.41476869 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.38049775 |
| 13 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.35487618 |
| 14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.28871288 |
| 15 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.25985666 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.24648016 |
| 17 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.24357274 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.15238425 |
| 19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.05186191 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.02442760 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.97287008 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.93917045 |
| 23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.93364386 |
| 24 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.91982748 |
| 25 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.80221089 |
| 26 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.77929639 |
| 27 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.77239094 |
| 28 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.74163316 |
| 29 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.72412703 |
| 30 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.69819518 |
| 31 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.69748629 |
| 32 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.67643935 |
| 33 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.61040707 |
| 34 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.59310958 |
| 35 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.57991199 |
| 36 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.52449655 |
| 37 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.46779670 |
| 38 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.46776006 |
| 39 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.46606196 |
| 40 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.46084420 |
| 41 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.44216718 |
| 42 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.41470724 |
| 43 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.40347483 |
| 44 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.39783807 |
| 45 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.39160787 |
| 46 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.38608540 |
| 47 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.38162739 |
| 48 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.37644889 |
| 49 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.36955826 |
| 50 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.36222660 |
| 51 | AR_25329375_ChIP-Seq_VCAP_Human | 1.34507746 |
| 52 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.33885342 |
| 53 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.33759175 |
| 54 | P300_19829295_ChIP-Seq_ESCs_Human | 1.31498787 |
| 55 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.31207330 |
| 56 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.31077872 |
| 57 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.29784361 |
| 58 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.29098477 |
| 59 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.28606768 |
| 60 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.28158936 |
| 61 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.27828655 |
| 62 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25930174 |
| 63 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.25581421 |
| 64 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.25298804 |
| 65 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.25033704 |
| 66 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.24599571 |
| 67 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.24532281 |
| 68 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.23295330 |
| 69 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.22832651 |
| 70 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.22516015 |
| 71 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.22432156 |
| 72 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.22169978 |
| 73 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.20914830 |
| 74 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.19566081 |
| 75 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.19399774 |
| 76 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.18366206 |
| 77 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.18366206 |
| 78 | * AR_19668381_ChIP-Seq_PC3_Human | 1.17748855 |
| 79 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.17508687 |
| 80 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.16809822 |
| 81 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.15477757 |
| 82 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.15103414 |
| 83 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.15051466 |
| 84 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.14692212 |
| 85 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.14303715 |
| 86 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.13115326 |
| 87 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.12899189 |
| 88 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.12445445 |
| 89 | TP53_16413492_ChIP-PET_HCT116_Human | 1.11688197 |
| 90 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.10546443 |
| 91 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.09722786 |
| 92 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.09149481 |
| 93 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.08600182 |
| 94 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08536538 |
| 95 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.08053047 |
| 96 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.07429669 |
| 97 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.07285889 |
| 98 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.07083568 |
| 99 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.06724199 |
| 100 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.06289783 |
| 101 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04857901 |
| 102 | RXR_22108803_ChIP-Seq_LS180_Human | 1.04713946 |
| 103 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03855980 |
| 104 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.03348487 |
| 105 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.02691243 |
| 106 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.01597881 |
| 107 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.00676593 |
| 108 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.00585874 |
| 109 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.98754498 |
| 110 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.98527157 |
| 111 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.98504579 |
| 112 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98240040 |
| 113 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.97182715 |
| 114 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.97174662 |
| 115 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.95621920 |
| 116 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.95611317 |
| 117 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.95490887 |
| 118 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.95330704 |
| 119 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.94452552 |
| 120 | VDR_22108803_ChIP-Seq_LS180_Human | 0.93518641 |
| 121 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.93242101 |
| 122 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.92196073 |
| 123 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.92162573 |
| 124 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.92107100 |
| 125 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92107100 |
| 126 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.92091592 |
| 127 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.92022571 |
| 128 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.91970071 |
| 129 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.91631415 |
| 130 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.90800892 |
| 131 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.90800892 |
| 132 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.89494595 |
| 133 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.89442183 |
| 134 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.89232608 |
| 135 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.89047242 |
| 136 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.88612930 |
| 137 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87505604 |
| 138 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.87059639 |
| 139 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.87035518 |
| 140 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.86373813 |
| 141 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.86255094 |
| 142 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.84885320 |
| 143 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.84666359 |
| 144 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.84552876 |
| 145 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.84011118 |
| 146 | FUS_26573619_Chip-Seq_HEK293_Human | 0.83643647 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.12806720 |
| 2 | MP0003880_abnormal_central_pattern | 4.68202021 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 3.98256585 |
| 4 | MP0002822_catalepsy | 3.60050961 |
| 5 | MP0009745_abnormal_behavioral_response | 3.46728467 |
| 6 | MP0004270_analgesia | 3.32858410 |
| 7 | * MP0002063_abnormal_learning/memory/cond | 3.22279068 |
| 8 | MP0002064_seizures | 2.93325586 |
| 9 | MP0002735_abnormal_chemical_nociception | 2.74920250 |
| 10 | * MP0002572_abnormal_emotion/affect_behav | 2.63573996 |
| 11 | MP0002009_preneoplasia | 2.54081267 |
| 12 | MP0001501_abnormal_sleep_pattern | 2.51557721 |
| 13 | MP0001968_abnormal_touch/_nociception | 2.46397985 |
| 14 | MP0009046_muscle_twitch | 2.36245087 |
| 15 | MP0002272_abnormal_nervous_system | 2.35222755 |
| 16 | MP0005409_darkened_coat_color | 2.33187231 |
| 17 | MP0003868_abnormal_feces_composition | 2.21120100 |
| 18 | MP0001486_abnormal_startle_reflex | 2.18439982 |
| 19 | MP0009840_abnormal_foam_cell | 2.17872985 |
| 20 | MP0001440_abnormal_grooming_behavior | 2.11654652 |
| 21 | MP0002736_abnormal_nociception_after | 2.08352050 |
| 22 | MP0003329_amyloid_beta_deposits | 2.08018327 |
| 23 | MP0009780_abnormal_chondrocyte_physiolo | 1.93608429 |
| 24 | MP0002734_abnormal_mechanical_nocicepti | 1.92575619 |
| 25 | MP0004036_abnormal_muscle_relaxation | 1.81419885 |
| 26 | MP0005423_abnormal_somatic_nervous | 1.72592350 |
| 27 | MP0002067_abnormal_sensory_capabilities | 1.69006006 |
| 28 | MP0003866_abnormal_defecation | 1.67635095 |
| 29 | MP0010352_gastrointestinal_tract_polyps | 1.64834718 |
| 30 | MP0004019_abnormal_vitamin_homeostasis | 1.62353174 |
| 31 | MP0008569_lethality_at_weaning | 1.61251973 |
| 32 | MP0002837_dystrophic_cardiac_calcinosis | 1.59750843 |
| 33 | MP0002138_abnormal_hepatobiliary_system | 1.59591041 |
| 34 | MP0004858_abnormal_nervous_system | 1.59420004 |
| 35 | MP0004147_increased_porphyrin_level | 1.58508881 |
| 36 | MP0001970_abnormal_pain_threshold | 1.56199138 |
| 37 | MP0003045_fibrosis | 1.54464559 |
| 38 | MP0003879_abnormal_hair_cell | 1.53861674 |
| 39 | MP0002909_abnormal_adrenal_gland | 1.52790291 |
| 40 | MP0004264_abnormal_extraembryonic_tissu | 1.51669819 |
| 41 | MP0002733_abnormal_thermal_nociception | 1.51547640 |
| 42 | MP0003787_abnormal_imprinting | 1.50869960 |
| 43 | MP0000778_abnormal_nervous_system | 1.48954473 |
| 44 | MP0005085_abnormal_gallbladder_physiolo | 1.48095215 |
| 45 | MP0010678_abnormal_skin_adnexa | 1.44367424 |
| 46 | MP0002557_abnormal_social/conspecific_i | 1.43135757 |
| 47 | MP0005670_abnormal_white_adipose | 1.42337766 |
| 48 | MP0005360_urolithiasis | 1.40261381 |
| 49 | MP0004924_abnormal_behavior | 1.39554167 |
| 50 | MP0005386_behavior/neurological_phenoty | 1.39554167 |
| 51 | MP0002184_abnormal_innervation | 1.39524751 |
| 52 | MP0005646_abnormal_pituitary_gland | 1.38666636 |
| 53 | MP0002971_abnormal_brown_adipose | 1.38466341 |
| 54 | MP0000751_myopathy | 1.36043245 |
| 55 | MP0001502_abnormal_circadian_rhythm | 1.34471108 |
| 56 | MP0003075_altered_response_to | 1.33388891 |
| 57 | MP0001756_abnormal_urination | 1.33176571 |
| 58 | MP0010368_abnormal_lymphatic_system | 1.32990701 |
| 59 | MP0004811_abnormal_neuron_physiology | 1.32478595 |
| 60 | MP0004885_abnormal_endolymph | 1.30155633 |
| 61 | MP0005332_abnormal_amino_acid | 1.29197860 |
| 62 | MP0003633_abnormal_nervous_system | 1.28545714 |
| 63 | MP0004087_abnormal_muscle_fiber | 1.28449960 |
| 64 | MP0002106_abnormal_muscle_physiology | 1.26748621 |
| 65 | MP0001905_abnormal_dopamine_level | 1.22950308 |
| 66 | MP0010234_abnormal_vibrissa_follicle | 1.22112652 |
| 67 | MP0008875_abnormal_xenobiotic_pharmacok | 1.21473655 |
| 68 | MP0004084_abnormal_cardiac_muscle | 1.19665436 |
| 69 | MP0005365_abnormal_bile_salt | 1.19518465 |
| 70 | MP0005166_decreased_susceptibility_to | 1.18905911 |
| 71 | MP0002066_abnormal_motor_capabilities/c | 1.18728737 |
| 72 | MP0002139_abnormal_hepatobiliary_system | 1.18225918 |
| 73 | MP0004142_abnormal_muscle_tone | 1.18095770 |
| 74 | MP0002882_abnormal_neuron_morphology | 1.17365843 |
| 75 | MP0010386_abnormal_urinary_bladder | 1.17160639 |
| 76 | MP0004215_abnormal_myocardial_fiber | 1.16844806 |
| 77 | MP0005551_abnormal_eye_electrophysiolog | 1.15377900 |
| 78 | MP0002876_abnormal_thyroid_physiology | 1.13615180 |
| 79 | MP0000747_muscle_weakness | 1.12605516 |
| 80 | MP0000604_amyloidosis | 1.12283439 |
| 81 | MP0000003_abnormal_adipose_tissue | 1.11304788 |
| 82 | MP0000955_abnormal_spinal_cord | 1.10476076 |
| 83 | MP0001984_abnormal_olfaction | 1.10224163 |
| 84 | MP0006138_congestive_heart_failure | 1.10084256 |
| 85 | MP0003631_nervous_system_phenotype | 1.07655418 |
| 86 | MP0000681_abnormal_thyroid_gland | 1.06306266 |
| 87 | MP0000230_abnormal_systemic_arterial | 1.05648857 |
| 88 | MP0002269_muscular_atrophy | 1.05646218 |
| 89 | MP0005330_cardiomyopathy | 1.05212751 |
| 90 | MP0005369_muscle_phenotype | 1.03582454 |
| 91 | MP0010155_abnormal_intestine_physiology | 1.02595868 |
| 92 | MP0005666_abnormal_adipose_tissue | 1.00008188 |
| 93 | MP0004484_altered_response_of | 0.99858266 |
| 94 | MP0003300_gastrointestinal_ulcer | 0.99477962 |
| 95 | MP0002078_abnormal_glucose_homeostasis | 0.97753000 |
| 96 | MP0005375_adipose_tissue_phenotype | 0.97501252 |
| 97 | MP0006276_abnormal_autonomic_nervous | 0.96880934 |
| 98 | MP0002896_abnormal_bone_mineralization | 0.96521323 |
| 99 | * MP0009643_abnormal_urine_homeostasis | 0.96127093 |
| 100 | MP0005535_abnormal_body_temperature | 0.95739104 |
| 101 | MP0002118_abnormal_lipid_homeostasis | 0.95722191 |
| 102 | MP0004085_abnormal_heartbeat | 0.94217470 |
| 103 | * MP0001765_abnormal_ion_homeostasis | 0.94088307 |
| 104 | MP0002229_neurodegeneration | 0.93486986 |
| 105 | MP0004043_abnormal_pH_regulation | 0.93202926 |
| 106 | MP0008874_decreased_physiological_sensi | 0.92965400 |
| 107 | MP0003718_maternal_effect | 0.92785424 |
| 108 | MP0001177_atelectasis | 0.92334836 |
| 109 | MP0002972_abnormal_cardiac_muscle | 0.92147485 |
| 110 | MP0000759_abnormal_skeletal_muscle | 0.89888832 |
| 111 | MP0002069_abnormal_eating/drinking_beha | 0.89286051 |
| 112 | MP0008872_abnormal_physiological_respon | 0.88704918 |
| 113 | MP0000383_abnormal_hair_follicle | 0.88457805 |
| 114 | MP0002127_abnormal_cardiovascular_syste | 0.86812242 |
| 115 | MP0001188_hyperpigmentation | 0.86156169 |
| 116 | MP0001664_abnormal_digestion | 0.85542630 |
| 117 | MP0004130_abnormal_muscle_cell | 0.84170640 |
| 118 | MP0003690_abnormal_glial_cell | 0.84040645 |
| 119 | MP0005448_abnormal_energy_balance | 0.83710530 |
| 120 | MP0002166_altered_tumor_susceptibility | 0.83247201 |
| 121 | MP0002332_abnormal_exercise_endurance | 0.82735770 |
| 122 | MP0010329_abnormal_lipoprotein_level | 0.82590445 |
| 123 | MP0004145_abnormal_muscle_electrophysio | 0.81601016 |
| 124 | MP0002090_abnormal_vision | 0.80262561 |
| 125 | MP0009115_abnormal_fat_cell | 0.79858022 |
| 126 | MP0001299_abnormal_eye_distance/ | 0.79380466 |
| 127 | * MP0002152_abnormal_brain_morphology | 0.79120254 |
| 128 | MP0003091_abnormal_cell_migration | 0.78766419 |
| 129 | MP0008961_abnormal_basal_metabolism | 0.77846461 |
| 130 | MP0003632_abnormal_nervous_system | 0.77713396 |
| 131 | MP0005385_cardiovascular_system_phenoty | 0.77005700 |
| 132 | MP0001544_abnormal_cardiovascular_syste | 0.77005700 |
| 133 | MP0004510_myositis | 0.76911690 |
| 134 | MP0000465_gastrointestinal_hemorrhage | 0.76498338 |
| 135 | MP0003252_abnormal_bile_duct | 0.74814729 |
| 136 | MP0000477_abnormal_intestine_morphology | 0.74699029 |
| 137 | MP0005171_absent_coat_pigmentation | 0.72122613 |
| 138 | MP0001963_abnormal_hearing_physiology | 0.71578049 |
| 139 | MP0003137_abnormal_impulse_conducting | 0.71341211 |
| 140 | MP0005595_abnormal_vascular_smooth | 0.70897946 |
| 141 | MP0001529_abnormal_vocalization | 0.67746033 |
| 142 | MP0005620_abnormal_muscle_contractility | 0.66451413 |
| 143 | MP0005645_abnormal_hypothalamus_physiol | 0.65261203 |
| 144 | MP0001485_abnormal_pinna_reflex | 0.64351132 |
| 145 | MP0005187_abnormal_penis_morphology | 0.63874528 |
| 146 | MP0001666_abnormal_nutrient_absorption | 0.63710685 |
| 147 | MP0003646_muscle_fatigue | 0.61992245 |
| 148 | MP0003183_abnormal_peptide_metabolism | 0.61668329 |
| 149 | MP0000013_abnormal_adipose_tissue | 0.61505746 |
| 150 | MP0000749_muscle_degeneration | 0.61233974 |
| 151 | MP0004233_abnormal_muscle_weight | 0.60063634 |
| 152 | MP0002234_abnormal_pharynx_morphology | 0.59290022 |
| 153 | MP0005167_abnormal_blood-brain_barrier | 0.59213983 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.09780423 |
| 2 | Myokymia (HP:0002411) | 6.15276414 |
| 3 | Focal seizures (HP:0007359) | 5.33487340 |
| 4 | Visual hallucinations (HP:0002367) | 4.67772235 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.65513906 |
| 6 | Progressive cerebellar ataxia (HP:0002073) | 4.34444375 |
| 7 | Hyperventilation (HP:0002883) | 4.33920227 |
| 8 | Atonic seizures (HP:0010819) | 4.24849142 |
| 9 | Febrile seizures (HP:0002373) | 4.21699987 |
| 10 | * Hyperkalemia (HP:0002153) | 4.18703888 |
| 11 | Abnormality of chloride homeostasis (HP:0011422) | 4.17283098 |
| 12 | Absence seizures (HP:0002121) | 4.11359125 |
| 13 | Muscle fiber inclusion bodies (HP:0100299) | 4.05017812 |
| 14 | Dialeptic seizures (HP:0011146) | 3.96520758 |
| 15 | Nemaline bodies (HP:0003798) | 3.91065505 |
| 16 | Malnutrition (HP:0004395) | 3.90288433 |
| 17 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.85832032 |
| 18 | Generalized tonic-clonic seizures (HP:0002069) | 3.72267903 |
| 19 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.68923945 |
| 20 | Abnormality of the lower motor neuron (HP:0002366) | 3.68218912 |
| 21 | * Hyperactive renin-angiotensin system (HP:0000841) | 3.67002983 |
| 22 | Action tremor (HP:0002345) | 3.60626980 |
| 23 | Nuclear cataract (HP:0100018) | 3.59772194 |
| 24 | * Abnormality of potassium homeostasis (HP:0011042) | 3.45388237 |
| 25 | Dysmetria (HP:0001310) | 3.34801409 |
| 26 | Rectal prolapse (HP:0002035) | 3.25308317 |
| 27 | Amblyopia (HP:0000646) | 3.24106349 |
| 28 | Gaze-evoked nystagmus (HP:0000640) | 3.13998657 |
| 29 | Dysdiadochokinesis (HP:0002075) | 3.12945904 |
| 30 | Type 1 muscle fiber predominance (HP:0003803) | 3.10008504 |
| 31 | Epileptiform EEG discharges (HP:0011182) | 3.05902159 |
| 32 | Broad-based gait (HP:0002136) | 3.02332742 |
| 33 | Hypokalemia (HP:0002900) | 3.00816024 |
| 34 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.97511107 |
| 35 | Papillary thyroid carcinoma (HP:0002895) | 2.88236438 |
| 36 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.86999335 |
| 37 | Hyporeflexia of lower limbs (HP:0002600) | 2.85538210 |
| 38 | Cerebral inclusion bodies (HP:0100314) | 2.84530232 |
| 39 | Anxiety (HP:0000739) | 2.84296004 |
| 40 | Double outlet right ventricle (HP:0001719) | 2.80995206 |
| 41 | Congenital malformation of the right heart (HP:0011723) | 2.80995206 |
| 42 | Genetic anticipation (HP:0003743) | 2.80555515 |
| 43 | Excessive salivation (HP:0003781) | 2.80270749 |
| 44 | Drooling (HP:0002307) | 2.80270749 |
| 45 | * Abnormality of renin-angiotensin system (HP:0000847) | 2.80070058 |
| 46 | Abnormal social behavior (HP:0012433) | 2.79816587 |
| 47 | Impaired social interactions (HP:0000735) | 2.79816587 |
| 48 | Syncope (HP:0001279) | 2.78936239 |
| 49 | Scanning speech (HP:0002168) | 2.78848209 |
| 50 | Hematochezia (HP:0002573) | 2.78189160 |
| 51 | Hyperphosphatemia (HP:0002905) | 2.77899492 |
| 52 | Muscle fiber splitting (HP:0003555) | 2.75482159 |
| 53 | Supranuclear gaze palsy (HP:0000605) | 2.75476329 |
| 54 | Postural instability (HP:0002172) | 2.73668745 |
| 55 | Flat acetabular roof (HP:0003180) | 2.72694378 |
| 56 | Papilledema (HP:0001085) | 2.71158171 |
| 57 | Poor eye contact (HP:0000817) | 2.71061667 |
| 58 | Ventricular fibrillation (HP:0001663) | 2.69197333 |
| 59 | Exercise-induced myalgia (HP:0003738) | 2.68146046 |
| 60 | Heart block (HP:0012722) | 2.67146546 |
| 61 | Depression (HP:0000716) | 2.66566989 |
| 62 | EMG: myopathic abnormalities (HP:0003458) | 2.66046003 |
| 63 | Truncal ataxia (HP:0002078) | 2.65079223 |
| 64 | Fat malabsorption (HP:0002630) | 2.60022533 |
| 65 | Asymmetric septal hypertrophy (HP:0001670) | 2.55339513 |
| 66 | Neurofibrillary tangles (HP:0002185) | 2.53988089 |
| 67 | Abnormal atrioventricular conduction (HP:0005150) | 2.52415789 |
| 68 | EEG with generalized epileptiform discharges (HP:0011198) | 2.52377622 |
| 69 | Confusion (HP:0001289) | 2.44382365 |
| 70 | Abnormal biliary tract morphology (HP:0012440) | 2.42729874 |
| 71 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.41787130 |
| 72 | Status epilepticus (HP:0002133) | 2.41208293 |
| 73 | Dysmetric saccades (HP:0000641) | 2.35462659 |
| 74 | Subaortic stenosis (HP:0001682) | 2.34843252 |
| 75 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.34843252 |
| 76 | Hemiparesis (HP:0001269) | 2.33569046 |
| 77 | Hypsarrhythmia (HP:0002521) | 2.32307268 |
| 78 | Intention tremor (HP:0002080) | 2.32216379 |
| 79 | Difficulty running (HP:0009046) | 2.31050124 |
| 80 | Impaired smooth pursuit (HP:0007772) | 2.30425229 |
| 81 | Abnormal eating behavior (HP:0100738) | 2.29141762 |
| 82 | Bundle branch block (HP:0011710) | 2.29100043 |
| 83 | Abnormality of vitamin B metabolism (HP:0004340) | 2.27028723 |
| 84 | Thickened helices (HP:0000391) | 2.27011001 |
| 85 | Biliary tract neoplasm (HP:0100574) | 2.26991150 |
| 86 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.26983514 |
| 87 | Absent speech (HP:0001344) | 2.24355258 |
| 88 | Neck muscle weakness (HP:0000467) | 2.23939239 |
| 89 | Distal arthrogryposis (HP:0005684) | 2.23723694 |
| 90 | Exercise-induced muscle cramps (HP:0003710) | 2.22794196 |
| 91 | Abnormal glucose tolerance (HP:0001952) | 2.21459798 |
| 92 | Sudden death (HP:0001699) | 2.20954274 |
| 93 | Hemiplegia (HP:0002301) | 2.20133929 |
| 94 | Chronic diarrhea (HP:0002028) | 2.19673225 |
| 95 | Ileus (HP:0002595) | 2.19359038 |
| 96 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.18471936 |
| 97 | Hydroxyprolinuria (HP:0003080) | 2.17649216 |
| 98 | Abnormality of proline metabolism (HP:0010907) | 2.17649216 |
| 99 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.17313290 |
| 100 | Alkalosis (HP:0001948) | 2.16649226 |
| 101 | Blue irides (HP:0000635) | 2.15213825 |
| 102 | Congenital sensorineural hearing impairment (HP:0008527) | 2.15158731 |
| 103 | Stereotypic behavior (HP:0000733) | 2.12576747 |
| 104 | Bradykinesia (HP:0002067) | 2.12501072 |
| 105 | * Decreased circulating renin level (HP:0003351) | 2.11322444 |
| 106 | Diplopia (HP:0000651) | 2.09918875 |
| 107 | Abnormality of binocular vision (HP:0011514) | 2.09918875 |
| 108 | Generalized myoclonic seizures (HP:0002123) | 2.08253610 |
| 109 | Impaired vibratory sensation (HP:0002495) | 2.06927019 |
| 110 | Ventricular tachycardia (HP:0004756) | 2.03950234 |
| 111 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.03861240 |
| 112 | Focal dystonia (HP:0004373) | 2.03627594 |
| 113 | Abnormal EKG (HP:0003115) | 2.03558228 |
| 114 | Torticollis (HP:0000473) | 2.02421289 |
| 115 | Abnormality of vitamin metabolism (HP:0100508) | 2.00892380 |
| 116 | Neoplasm of the small intestine (HP:0100833) | 2.00756762 |
| 117 | Abnormality of the calf musculature (HP:0001430) | 2.00205948 |
| 118 | Proximal tubulopathy (HP:0000114) | 2.00008790 |
| 119 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.98595865 |
| 120 | Calf muscle hypertrophy (HP:0008981) | 1.98259555 |
| 121 | Atrioventricular block (HP:0001678) | 1.97333348 |
| 122 | Round ear (HP:0100830) | 1.96321693 |
| 123 | Choroideremia (HP:0001139) | 1.95639440 |
| 124 | Increased connective tissue (HP:0009025) | 1.95067577 |
| 125 | Palpitations (HP:0001962) | 1.93768312 |
| 126 | Urinary urgency (HP:0000012) | 1.93628283 |
| 127 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.93044213 |
| 128 | Myopathic facies (HP:0002058) | 1.92084584 |
| 129 | Prolonged QT interval (HP:0001657) | 1.89371060 |
| 130 | Incomplete penetrance (HP:0003829) | 1.89278288 |
| 131 | Glucose intolerance (HP:0000833) | 1.88577417 |
| 132 | Ankle clonus (HP:0011448) | 1.88061573 |
| 133 | Polar cataract (HP:0010696) | 1.87991817 |
| 134 | Psychosis (HP:0000709) | 1.87299432 |
| 135 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.87103416 |
| 136 | Ventricular arrhythmia (HP:0004308) | 1.86913472 |
| 137 | Muscle stiffness (HP:0003552) | 1.85794614 |
| 138 | Rapidly progressive (HP:0003678) | 1.85666730 |
| 139 | Pigmentary retinal degeneration (HP:0001146) | 1.85431984 |
| 140 | Ketoacidosis (HP:0001993) | 1.84531137 |
| 141 | Lower limb asymmetry (HP:0100559) | 1.83734136 |
| 142 | Abnormality of salivation (HP:0100755) | 1.83035589 |
| 143 | Hypercortisolism (HP:0001578) | 1.82545209 |
| 144 | Protruding tongue (HP:0010808) | 1.82528499 |
| 145 | Spastic gait (HP:0002064) | 1.82098442 |
| 146 | * Adrenal overactivity (HP:0002717) | 1.81172990 |
| 147 | Zonular cataract (HP:0010920) | 1.80659519 |
| 148 | * Hyperaldosteronism (HP:0000859) | 1.79702756 |
| 149 | Visceral angiomatosis (HP:0100761) | 1.79467842 |
| 150 | Fair hair (HP:0002286) | 1.79195676 |
| 151 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.78827021 |
| 152 | Metabolic alkalosis (HP:0200114) | 1.78776053 |
| 153 | Gait ataxia (HP:0002066) | 1.78323582 |
| 154 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.76336778 |
| 155 | Anosmia (HP:0000458) | 1.76331910 |
| 156 | Primary atrial arrhythmia (HP:0001692) | 1.75632211 |
| 157 | Central scotoma (HP:0000603) | 1.75516672 |
| 158 | Increased variability in muscle fiber diameter (HP:0003557) | 1.75209760 |
| 159 | Megalencephaly (HP:0001355) | 1.73816407 |
| 160 | Rhabdomyolysis (HP:0003201) | 1.73126820 |
| 161 | Lower limb amyotrophy (HP:0007210) | 1.73069395 |
| 162 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.72963767 |
| 163 | Hypoplastic nipples (HP:0002557) | 1.71384156 |
| 164 | Oligodactyly (hands) (HP:0001180) | 1.70797177 |
| 165 | Intrahepatic cholestasis (HP:0001406) | 1.70394702 |
| 166 | Global brain atrophy (HP:0002283) | 1.70340484 |
| 167 | Myoglobinuria (HP:0002913) | 1.70147215 |
| 168 | Steatorrhea (HP:0002570) | 1.69728067 |
| 169 | Progressive sensorineural hearing impairment (HP:0000408) | 1.68540840 |
| 170 | Frequent falls (HP:0002359) | 1.68419933 |
| 171 | Lip pit (HP:0100267) | 1.67736128 |
| 172 | Atrial fibrillation (HP:0005110) | 1.67454646 |
| 173 | Ketosis (HP:0001946) | 1.66451396 |
| 174 | Craniofacial dystonia (HP:0012179) | 1.65737279 |
| 175 | Striae distensae (HP:0001065) | 1.65619247 |
| 176 | Intellectual disability, severe (HP:0010864) | 1.65532342 |
| 177 | Hip contracture (HP:0003273) | 1.65331503 |
| 178 | Distal lower limb muscle weakness (HP:0009053) | 1.63217577 |
| 179 | Progressive inability to walk (HP:0002505) | 1.62891614 |
| 180 | Retinal dysplasia (HP:0007973) | 1.62547817 |
| 181 | Right ventricular cardiomyopathy (HP:0011663) | 1.62270025 |
| 182 | Insidious onset (HP:0003587) | 1.61804496 |
| 183 | Termporal pattern (HP:0011008) | 1.61804496 |
| 184 | Supraventricular tachycardia (HP:0004755) | 1.59713817 |
| 185 | Generalized hypopigmentation of hair (HP:0011358) | 1.59318605 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 6.23584415 |
| 2 | EPHA4 | 5.83507798 |
| 3 | OBSCN | 3.69396977 |
| 4 | MAP2K6 | 2.67214756 |
| 5 | ACVR1B | 2.66553804 |
| 6 | MAP3K9 | 2.64283252 |
| 7 | MAP3K4 | 2.63365050 |
| 8 | RIPK1 | 2.49591618 |
| 9 | RIPK4 | 2.26530853 |
| 10 | MAP2K7 | 2.25163338 |
| 11 | NLK | 2.19547752 |
| 12 | TNIK | 2.13400882 |
| 13 | MST1R | 2.13352784 |
| 14 | MINK1 | 2.02185277 |
| 15 | KSR2 | 1.99237466 |
| 16 | PRKD3 | 1.95141615 |
| 17 | PRPF4B | 1.87332751 |
| 18 | PIK3CA | 1.80708106 |
| 19 | MAP2K4 | 1.79836795 |
| 20 | DAPK2 | 1.79445660 |
| 21 | CDK12 | 1.78693125 |
| 22 | TTN | 1.68303145 |
| 23 | KSR1 | 1.58051628 |
| 24 | LMTK2 | 1.56934490 |
| 25 | MET | 1.55773346 |
| 26 | FES | 1.51320589 |
| 27 | NTRK2 | 1.50648101 |
| 28 | NME1 | 1.46763849 |
| 29 | CAMK2B | 1.46309662 |
| 30 | PTK2B | 1.46068093 |
| 31 | MARK1 | 1.45594549 |
| 32 | NEK6 | 1.44077559 |
| 33 | MAP3K13 | 1.40718640 |
| 34 | PAK6 | 1.38836939 |
| 35 | PLK2 | 1.38282491 |
| 36 | MAP3K2 | 1.36021320 |
| 37 | CDK5 | 1.36012961 |
| 38 | STK38 | 1.34180727 |
| 39 | STK39 | 1.33382965 |
| 40 | DAPK1 | 1.31962943 |
| 41 | CAMK2A | 1.30532974 |
| 42 | IRAK4 | 1.28065666 |
| 43 | PIK3CG | 1.24358635 |
| 44 | MAP3K7 | 1.22129959 |
| 45 | CAMKK1 | 1.20915128 |
| 46 | STK24 | 1.20527735 |
| 47 | PINK1 | 1.19763770 |
| 48 | TRPM7 | 1.19202702 |
| 49 | FER | 1.19167717 |
| 50 | PRKCG | 1.16026534 |
| 51 | MAP3K12 | 1.14594927 |
| 52 | FGFR3 | 1.13149592 |
| 53 | MARK2 | 1.12529684 |
| 54 | CASK | 1.10272522 |
| 55 | MAPK13 | 1.10237013 |
| 56 | ARAF | 1.08287857 |
| 57 | INSRR | 1.07643666 |
| 58 | CAMK1 | 1.06201145 |
| 59 | MELK | 1.01402794 |
| 60 | JAK1 | 1.00802867 |
| 61 | PNCK | 1.00659071 |
| 62 | NTRK1 | 0.98589242 |
| 63 | PDK2 | 0.97977258 |
| 64 | WNK1 | 0.97033041 |
| 65 | PHKG2 | 0.95537933 |
| 66 | PHKG1 | 0.95537933 |
| 67 | GRK5 | 0.94724439 |
| 68 | SGK494 | 0.94406479 |
| 69 | SGK223 | 0.94406479 |
| 70 | EPHA2 | 0.93348380 |
| 71 | SGK2 | 0.92620358 |
| 72 | CAMK2D | 0.88019126 |
| 73 | MAPK11 | 0.87104978 |
| 74 | SIK2 | 0.86600843 |
| 75 | BMPR2 | 0.85997781 |
| 76 | PRKG2 | 0.84483177 |
| 77 | SGK1 | 0.83646009 |
| 78 | DMPK | 0.82763451 |
| 79 | RAF1 | 0.82566359 |
| 80 | MAP3K10 | 0.81208447 |
| 81 | SGK3 | 0.80578036 |
| 82 | TAOK2 | 0.79220037 |
| 83 | PAK3 | 0.77940022 |
| 84 | EPHB1 | 0.77397376 |
| 85 | FRK | 0.75546866 |
| 86 | MOS | 0.73616239 |
| 87 | PDK1 | 0.73338849 |
| 88 | TIE1 | 0.72948608 |
| 89 | PRKCE | 0.71771409 |
| 90 | MAP3K1 | 0.71622433 |
| 91 | CAMK2G | 0.70674323 |
| 92 | PRKAA1 | 0.69942984 |
| 93 | MAP2K2 | 0.69624002 |
| 94 | FGR | 0.69437787 |
| 95 | PRKCH | 0.68429429 |
| 96 | PDPK1 | 0.67635297 |
| 97 | EEF2K | 0.66126312 |
| 98 | MAP2K1 | 0.64725448 |
| 99 | TAOK3 | 0.64590762 |
| 100 | TRIB3 | 0.63136694 |
| 101 | LATS1 | 0.61455503 |
| 102 | MAPK7 | 0.61082660 |
| 103 | CSNK1G2 | 0.59917601 |
| 104 | EPHA3 | 0.59906597 |
| 105 | ERN1 | 0.58319327 |
| 106 | DYRK1A | 0.57082424 |
| 107 | AKT3 | 0.52619260 |
| 108 | PRKCZ | 0.51693858 |
| 109 | MYLK | 0.51674803 |
| 110 | CDC42BPA | 0.51405454 |
| 111 | TYRO3 | 0.50792587 |
| 112 | PRKD2 | 0.50692189 |
| 113 | ICK | 0.49858897 |
| 114 | PRKG1 | 0.49200609 |
| 115 | MUSK | 0.48517192 |
| 116 | STK11 | 0.48241662 |
| 117 | RET | 0.48115465 |
| 118 | CAMK1G | 0.47371053 |
| 119 | RPS6KA3 | 0.47333365 |
| 120 | ZAP70 | 0.47224251 |
| 121 | CAMK4 | 0.47162132 |
| 122 | CDK18 | 0.46644546 |
| 123 | CDK15 | 0.46248292 |
| 124 | PRKCA | 0.44828556 |
| 125 | UHMK1 | 0.44514687 |
| 126 | OXSR1 | 0.43883711 |
| 127 | JAK2 | 0.43825428 |
| 128 | CAMK1D | 0.43479070 |
| 129 | TYK2 | 0.43229877 |
| 130 | FYN | 0.43163355 |
| 131 | NEK9 | 0.41809560 |
| 132 | GRK6 | 0.41143535 |
| 133 | CDK14 | 0.41058103 |
| 134 | ROCK2 | 0.40958544 |
| 135 | FGFR4 | 0.40066654 |
| 136 | MAP3K3 | 0.38037052 |
| 137 | PRKAA2 | 0.37281592 |
| 138 | PRKACA | 0.36019216 |
| 139 | CDK11A | 0.35486066 |
| 140 | PRKCQ | 0.35074096 |
| 141 | PRKACB | 0.33092758 |
| 142 | CAMKK2 | 0.32727292 |
| 143 | PRKCB | 0.32391383 |
| 144 | DDR2 | 0.31413267 |
| 145 | BMX | 0.30703252 |
| 146 | PRKACG | 0.30466312 |
| 147 | MAPK10 | 0.30395282 |
| 148 | MAPK12 | 0.29846179 |
| 149 | PDK3 | 0.28032492 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.73318908 |
| 2 | Circadian entrainment_Homo sapiens_hsa04713 | 2.89297116 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.73911992 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.67691506 |
| 5 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.51711318 |
| 6 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.46336056 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.45003137 |
| 8 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.22810676 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.20506113 |
| 10 | Salivary secretion_Homo sapiens_hsa04970 | 2.18070509 |
| 11 | Olfactory transduction_Homo sapiens_hsa04740 | 2.15050331 |
| 12 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.07121630 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.97882209 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 1.91195670 |
| 15 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.89969837 |
| 16 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.87467084 |
| 17 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.77743835 |
| 18 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.72888157 |
| 19 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.72876699 |
| 20 | Taste transduction_Homo sapiens_hsa04742 | 1.70507418 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.67176937 |
| 22 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.67140370 |
| 23 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.65810654 |
| 24 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.62620495 |
| 25 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.60068315 |
| 26 | Renin secretion_Homo sapiens_hsa04924 | 1.58493591 |
| 27 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.56749137 |
| 28 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.54004528 |
| 29 | Long-term depression_Homo sapiens_hsa04730 | 1.48752758 |
| 30 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.41829433 |
| 31 | Cocaine addiction_Homo sapiens_hsa05030 | 1.41581111 |
| 32 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.40756962 |
| 33 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.37208090 |
| 34 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.37117199 |
| 35 | * Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.30171274 |
| 36 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.28100029 |
| 37 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.27463079 |
| 38 | Bile secretion_Homo sapiens_hsa04976 | 1.22749579 |
| 39 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.22452306 |
| 40 | ABC transporters_Homo sapiens_hsa02010 | 1.22290136 |
| 41 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.21528119 |
| 42 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.18039520 |
| 43 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.10125337 |
| 44 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.08568518 |
| 45 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.05093054 |
| 46 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.03819512 |
| 47 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.03131212 |
| 48 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.02578016 |
| 49 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.02559021 |
| 50 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.98260919 |
| 51 | Insulin resistance_Homo sapiens_hsa04931 | 0.96961683 |
| 52 | Gap junction_Homo sapiens_hsa04540 | 0.95372549 |
| 53 | Retinol metabolism_Homo sapiens_hsa00830 | 0.95357262 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94928059 |
| 55 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.93284887 |
| 56 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.93172249 |
| 57 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.89998914 |
| 58 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.89911715 |
| 59 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.88841979 |
| 60 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.87213471 |
| 61 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.87187543 |
| 62 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.87024505 |
| 63 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.86188362 |
| 64 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.85700028 |
| 65 | Glioma_Homo sapiens_hsa05214 | 0.84992210 |
| 66 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.81565246 |
| 67 | Tight junction_Homo sapiens_hsa04530 | 0.81452082 |
| 68 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.79535434 |
| 69 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.79311294 |
| 70 | Melanogenesis_Homo sapiens_hsa04916 | 0.77216956 |
| 71 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.76316442 |
| 72 | Phototransduction_Homo sapiens_hsa04744 | 0.76276020 |
| 73 | Axon guidance_Homo sapiens_hsa04360 | 0.75537497 |
| 74 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.74782233 |
| 75 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.74509285 |
| 76 | Adherens junction_Homo sapiens_hsa04520 | 0.73593289 |
| 77 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.72155650 |
| 78 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.71341389 |
| 79 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.71276040 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.71151358 |
| 81 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.71107646 |
| 82 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.68654210 |
| 83 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.68637836 |
| 84 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.68589101 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67808581 |
| 86 | Circadian rhythm_Homo sapiens_hsa04710 | 0.67729511 |
| 87 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.65845847 |
| 88 | Mineral absorption_Homo sapiens_hsa04978 | 0.65183655 |
| 89 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.65047976 |
| 90 | Endometrial cancer_Homo sapiens_hsa05213 | 0.64379793 |
| 91 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.61364898 |
| 92 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.60418081 |
| 93 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.59542247 |
| 94 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.58402998 |
| 95 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57536916 |
| 96 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.56387151 |
| 97 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.56257284 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55953170 |
| 99 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.53690159 |
| 100 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.50470598 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.50247323 |
| 102 | Galactose metabolism_Homo sapiens_hsa00052 | 0.49458940 |
| 103 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.48367992 |
| 104 | Thyroid cancer_Homo sapiens_hsa05216 | 0.46696541 |
| 105 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45248134 |
| 106 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.44606592 |
| 107 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43956702 |
| 108 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.43763582 |
| 109 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.43592885 |
| 110 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42366353 |
| 111 | Prion diseases_Homo sapiens_hsa05020 | 0.41674771 |
| 112 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.40988607 |
| 113 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.40759052 |
| 114 | Focal adhesion_Homo sapiens_hsa04510 | 0.40637844 |
| 115 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.39220267 |
| 116 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.37104983 |
| 117 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.36961422 |
| 118 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.36336893 |
| 119 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.36287068 |
| 120 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.34304275 |
| 121 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.32706964 |
| 122 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.32695028 |
| 123 | Alzheimers disease_Homo sapiens_hsa05010 | 0.32675630 |
| 124 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32650314 |
| 125 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.32570014 |
| 126 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.32248429 |
| 127 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.31719709 |
| 128 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.30610887 |
| 129 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.29298475 |
| 130 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.29262591 |
| 131 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.27858443 |
| 132 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.25710824 |
| 133 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.25496735 |
| 134 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.24823967 |

